<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01744301</url>
  </required_header>
  <id_info>
    <org_study_id>D9612N00017</org_study_id>
    <nct_id>NCT01744301</nct_id>
  </id_info>
  <brief_title>Acid Suppressing Drug Seizure Epidemiology Study</brief_title>
  <official_title>A Cohort Study With a Nested Case Control Analysis on the Association Between Acid-suppressing Drugs and Seizures Using THIN Database in the UK</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is

        1. to estimate the incidence of seizure in the general population and stratified by
           epilepsy status

        2. To estimate the relative risk of seizure associated with use of proton pump inhibitors
           and histamine 2 receptor antagonist and stratified by epilepsy status
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cohort study with a nested case control analysis on the association between
      acid-suppressing drugs and seizures using THIN database in the UK
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of seizure in the general population and stratified by epilepsy status.</measure>
    <time_frame>Participants will be followed for the duration of the study period 1 January 2005-31 December 2011, an expected average of 3 years.</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Follow-up of safety outcomes: First recorded entry of seizure.</measure>
    <time_frame>Participants will be followed for the duration of the study period 1 January 2005-31 December 2011, an expected average of 3 years.</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">8605</enrollment>
  <condition>Seizure</condition>
  <arm_group>
    <arm_group_label>All patients newly prescribed PPI</arm_group_label>
    <description>All patients newly prescribed PPI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>All patients newly prescribed H2RA</arm_group_label>
    <description>All patients newly prescribed H2RA</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Risk of seizure</intervention_name>
    <description>Patients newly prescribed PPI and H2RA, respectively</description>
    <arm_group_label>All patients newly prescribed PPI</arm_group_label>
    <arm_group_label>All patients newly prescribed H2RA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All individuals aged 20-84 years from 1 January 2005 to 31 December 2011, who have been
        enrolled with their primary care physician for at least 2 years and have a computerized
        prescription history of at least 1 year. Patients will have to be free of acid-suppressing
        drugs (PPI or H2RA) for at least one year, and never have a diagnosis of cancer, alcohol
        abuse or alcohol-related disease, or drug abuse.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary care physician for at least 2 years.

          -  Computerized prescription history of at least 1 year.

          -  Patients will have to be free of acid-suppressing drugs (PPI or H2RA) for at least one
             year.

          -  No diagnosis of cancer.

          -  No alcohol abuse or alcohol-related disease- No drug abuse.

        Exclusion Criteria:

          -  Patients with at least 1 prescription of PPI or H2RA in the year prior to start date.

          -  Cancer before start date.

          -  Alcohol abuse or alcohol-related disease before start date.

          -  Drug abuse before start date.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luis a Garcia Rodriguez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CEIFE (Centro Espanol de Investigacion Farmacoepidemiologica - Spanish Centre for Pharmacoepidemiologic Research )</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Sáez ME, González-Pérez A, Gaist D, Johansson S, Nagy P, García Rodríguez LA. Risk of seizure associated with use of acid-suppressive drugs: An observational cohort study. Epilepsy Behav. 2016 Sep;62:72-80. doi: 10.1016/j.yebeh.2016.06.039. Epub 2016 Jul 21.</citation>
    <PMID>27450309</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2012</study_first_submitted>
  <study_first_submitted_qc>December 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2012</study_first_posted>
  <last_update_submitted>September 8, 2016</last_update_submitted>
  <last_update_submitted_qc>September 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Seizure</keyword>
  <keyword>Acid-suppressing drugs</keyword>
  <keyword>Epidemiology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seizures</mesh_term>
  </condition_browse>
  <study_docs>
    <study_doc>
      <doc_id>CSR Study Report Synopsis</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7112&amp;studyid=674&amp;filename=D9612N00017_Seizure_Study_report_synopsis_FINAL_redacted.pdf</doc_url>
      <doc_comment>D9612N00017_Seizure_Study_report_synopsis_FINAL_redacted</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

